{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T03:03:19Z","timestamp":1763348599503},"reference-count":50,"publisher":"Impact Journals, LLC","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2023,11,30]]},"DOI":"10.18632\/aging.205242","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T16:10:30Z","timestamp":1701101430000},"page":"13312-13328","source":"Crossref","is-referenced-by-count":6,"title":["Prognostic significance and immunoinfiltration analysis of genes associated with epithelial-mesenchymal transition and energy metabolism in bladder urothelial carcinoma"],"prefix":"10.18632","volume":"15","author":[{"given":"Yifan","family":"Qiu","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Ye","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","article-title":"Epidemiology, Screening, and Prevention of Bladder Cancer.","volume":"5","author":"Lotan","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11934-018-0860-6","article-title":"Bladder Cancer Survivorship.","volume":"1","author":"Bhanvadia","year":"2018","journal-title":"Curr Urol Rep"},{"key":"3","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/medicina57080749","article-title":"Bladder Cancer: Current Challenges and Future Directions.","volume":"5","author":"Oszczud\u0142owski","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"4","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer.","volume":"38","author":"Kassouf","year":"2016","journal-title":"Lancet"},{"key":"5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/apm.13011","article-title":"Bacillus Calmette-Gu\u00e9rin immunotherapy for bladder cancer: a review of immunological aspects, clinical effects and BCG infections.","volume":"12","author":"Johansen","year":"2020","journal-title":"APMIS"},{"key":"6","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1080\/08820139.2022.2118606","article-title":"Immunotherapy for Bladder Cancer: Latest Advances and Ongoing Clinical Trials.","volume":"5","author":"Warlick","year":"2022","journal-title":"Immunol Invest"},{"key":"7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12943-019-1091-2","article-title":"Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4.","volume":"1","author":"Luo","year":"2019","journal-title":"Mol Cancer"},{"key":"8","doi-asserted-by":"publisher","first-page":"965100","DOI":"10.3389\/fgene.2022.965100","article-title":"Prognosis and immune infiltration analysis of endoplasmic reticulum stress-related genes in bladder urothelial carcinoma.","volume":"1","author":"Wang","year":"2022","journal-title":"Front Genet"},{"key":"9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12943-019-1030-2","article-title":"Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy.","volume":"1","author":"Jiang","year":"2019","journal-title":"Mol Cancer"},{"key":"10","doi-asserted-by":"publisher","first-page":"e2100997","DOI":"10.1002\/advs.202100997","article-title":"Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor Cells.","volume":"8","author":"Luo","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"11","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/ijms23020800","article-title":"The Epithelial-Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression.","volume":"2","author":"Manfioletti","year":"2022","journal-title":"Int J Mol Sci"},{"key":"12","doi-asserted-by":"publisher","first-page":"114395","DOI":"10.1016\/j.biopha.2023.114395","article-title":"Unraveling the function of epithelial-mesenchymal transition (EMT) in colorectal cancer: Metastasis, therapy response, and revisiting molecular pathways.","volume":"16","author":"Ertas","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12943-019-0976-4","article-title":"Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.","volume":"1","author":"Xiong","year":"2019","journal-title":"Mol Cancer"},{"key":"14","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.3390\/ijms22073418","article-title":"Gastric Cancer: Advances in Carcinogenesis Research and New Therapeutic Strategies.","volume":"2","author":"Varon","year":"2021","journal-title":"Int J Mol Sci"},{"key":"15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.canlet.2019.10.013","article-title":"Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion.","volume":"46","author":"Zhan","year":"2020","journal-title":"Cancer Lett"},{"key":"16","doi-asserted-by":"publisher","first-page":"6806","DOI":"10.3390\/ijms23126806","article-title":"Breast Cancer Metastasis: Mechanisms and Therapeutic Implications.","volume":"2","author":"Yoon","year":"2022","journal-title":"Int J Mol Sci"},{"key":"17","doi-asserted-by":"publisher","first-page":"613492","DOI":"10.3389\/fimmu.2021.613492","article-title":"Metabolism of Dendritic Cells in Tumor Microenvironment: For Immunotherapy.","volume":"1","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"key":"18","doi-asserted-by":"publisher","first-page":"1000321","DOI":"10.3389\/fimmu.2022.1000321","article-title":"An EMT-based risk score thoroughly predicts the clinical prognosis, tumor immune microenvironment and molecular subtypes of bladder cancer.","volume":"1","author":"Zu","year":"2022","journal-title":"Front Immunol"},{"key":"19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.urolonc.2018.04.010","article-title":"Metabolic changes in bladder cancer.","volume":"3","author":"Taylor JA","year":"2018","journal-title":"Urol Oncol"},{"key":"20","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1042\/CS20190587","article-title":"Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPAR\u03b3-mediated pathway in bladder cancer.","volume":"13","author":"Wang","year":"2019","journal-title":"Clin Sci (Lond)"},{"key":"21","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.3390\/ijms22115543","article-title":"Epithelial-Mesenchymal Transition (EMT) Induced by TGF-\u03b2 in Hepatocellular Carcinoma Cells Reprograms Lipid Metabolism.","volume":"2","author":"Fabregat","year":"2021","journal-title":"Int J Mol Sci"},{"key":"22","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/s12967-022-03679-y","article-title":"CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response.","volume":"2","author":"Bertucci","year":"2022","journal-title":"J Transl Med"},{"key":"23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2174\/156652410791316977","article-title":"CSPG4 in cancer: multiple roles.","volume":"1","author":"Ferrone","year":"2010","journal-title":"Curr Mol Med"},{"key":"24","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1089\/thy.2021.0067","article-title":"CSPG4 Is a Potential Therapeutic Target in Anaplastic Thyroid Cancer.","volume":"3","author":"Scognamiglio","year":"2021","journal-title":"Thyroid"},{"key":"25","doi-asserted-by":"publisher","first-page":"5942","DOI":"10.3390\/ijms20235942","article-title":"CSPG4 as Target for CAR-T-Cell Therapy of Various Tumor Entities-Merits and Challenges.","volume":"2","author":"Schaft","year":"2019","journal-title":"Int J Mol Sci"},{"key":"26","doi-asserted-by":"publisher","first-page":"1010428317724282","DOI":"10.1177\/1010428317724282","article-title":"Prognostic relevance of NG2\/CSPG4, CD44 and Ki-67 in patients with glioblastoma.","volume":"3","author":"Grigorieva","year":"2017","journal-title":"Tumour Biol"},{"key":"27","doi-asserted-by":"publisher","first-page":"676142","DOI":"10.3389\/fcell.2021.676142","article-title":"Comprehensive Analysis of Ferroptosis Regulators With Regard to PD-L1 and Immune Infiltration in Clear Cell Renal Cell Carcinoma.","volume":"9","author":"Xie","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"28","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1007\/s12072-022-10354-3","article-title":"A novel epithelial-mesenchymal transition gene signature for the immune status and prognosis of hepatocellular carcinoma.","volume":"1","author":"Yu","year":"2022","journal-title":"Hepatol Int"},{"key":"29","doi-asserted-by":"publisher","first-page":"3708231","DOI":"10.1155\/2020\/3708231","article-title":"Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.","volume":"202","author":"Wei","year":"2020","journal-title":"Biomed Res Int"},{"key":"30","doi-asserted-by":"publisher","first-page":"842019","DOI":"10.3389\/fbioe.2022.842019","article-title":"scMelody: An Enhanced Consensus-Based Clustering Model for Single-Cell Methylation Data by Reconstructing Cell-to-Cell Similarity.","volume":"1","author":"Fan","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"31","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1038\/srep06207","article-title":"Critical limitations of consensus clustering in class discovery.","volume":"4","author":"Li","year":"2014","journal-title":"Sci Rep"},{"key":"32","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1007\/s00432-022-04262-0","article-title":"PD-1, PD-L1 and cAMP immunohistochemical expressions are associated with worse oncological outcome in patients with bladder cancer.","volume":"14","author":"Cimino","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"33","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.2174\/1389450121666200326123700","article-title":"PD1\/PD-L1 Axis in Uro-oncology.","volume":"2","author":"Montironi","year":"2020","journal-title":"Curr Drug Targets"},{"key":"34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00262-020-02649-x","article-title":"Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC).","volume":"7","author":"Tian","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"35","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3390\/medicina57080769","article-title":"Neoadjuvant Immunotherapy for Muscle-Invasive Bladder Cancer.","volume":"5","author":"Xylinas","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"36","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41585-022-00608-y","article-title":"The dynamic roles of the bladder tumour microenvironment.","volume":"1","author":"Chan","year":"2022","journal-title":"Nat Rev Urol"},{"key":"37","doi-asserted-by":"publisher","first-page":"100715","DOI":"10.1016\/j.drup.2020.100715","article-title":"Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.","volume":"5","author":"Efferth","year":"2020","journal-title":"Drug Resist Updat"},{"key":"38","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.3390\/ijms19092724","article-title":"The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas.","volume":"1","author":"Annovazzi","year":"2018","journal-title":"Int J Mol Sci"},{"key":"39","doi-asserted-by":"publisher","first-page":"804466","DOI":"10.3389\/fonc.2022.804466","article-title":"Co-Expression and Combined Prognostic Value of CSPG4 and PDL1 in TP53-Aberrant Triple-Negative Breast Cancer.","volume":"1","author":"Ouyang","year":"2022","journal-title":"Front Oncol"},{"key":"40","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc2620","article-title":"Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.","volume":"9","author":"Weinberg","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"41","doi-asserted-by":"publisher","first-page":"166431","DOI":"10.1016\/j.bbadis.2022.166431","article-title":"Autophagy and EMT in cancer and metastasis: Who controls whom?","volume":"186","author":"Ghavami","year":"2022","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"42","doi-asserted-by":"publisher","first-page":"8285","DOI":"10.3390\/curroncol29110654","article-title":"PD-L1 Activity Is Associated with Partial EMT and Metabolic Reprogramming in Carcinomas.","volume":"2","author":"Jolly","year":"2022","journal-title":"Curr Oncol"},{"key":"43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13046-022-02377-3","article-title":"TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K\/AKT pathway in bladder cancer.","volume":"4","author":"Wang","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"44","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12967-022-03508-2","article-title":"Bladder cancer-derived exosomal KRT6B promotes invasion and metastasis by inducing EMT and regulating the immune microenvironment.","volume":"2","author":"Yang","year":"2022","journal-title":"J Transl Med"},{"key":"45","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/2211-5463.13580","article-title":"Establishment of a risk score model for bladder urothelial carcinoma based on energy metabolism-related genes and their relationships with immune infiltration.","volume":"1","author":"Mo","year":"2023","journal-title":"FEBS Open Bio"},{"key":"46","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/jcmm.14767","article-title":"An EMT-related gene signature for the prognosis of human bladder cancer.","volume":"2","author":"Tian","year":"2020","journal-title":"J Cell Mol Med"},{"key":"47","doi-asserted-by":"publisher","first-page":"109022","DOI":"10.1016\/j.cbi.2020.109022","article-title":"Thymoquinone suppresses invasion and metastasis in bladder cancer cells by reversing EMT through the Wnt\/\u03b2-catenin signaling pathway.","volume":"32","author":"Wang","year":"2020","journal-title":"Chem Biol Interact"},{"key":"48","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.3390\/cells9122669","article-title":"Profiling and Targeting of Energy and Redox Metabolism in Grade 2 Bladder Cancer Cells with Different Invasiveness Properties.","volume":"9","author":"Sacco","year":"2020","journal-title":"Cells"},{"key":"49","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1111\/cas.15047","article-title":"The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets.","volume":"11","author":"Allison","year":"2021","journal-title":"Cancer Sci"},{"key":"50","doi-asserted-by":"publisher","first-page":"954616","DOI":"10.3389\/fimmu.2022.954616","article-title":"Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer.","volume":"1","author":"Niu","year":"2022","journal-title":"Front Immunol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205242","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T14:34:11Z","timestamp":1701873251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":50,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2023,11,30]]}},"alternative-id":["205242","38015710"],"URL":"https:\/\/doi.org\/10.18632\/aging.205242","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]}}}